Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00432926 · ClinicalTrials.gov registry record · Phase 2
Behavior Change and Maintenance Intervention for HIV+ MSM Methamphetamine Users
A Phase 2 study, sponsored by University of California, San Diego.
- Completed
- Registry status
- Phase 2
- Development phase
- 429
- Enrollment target
NCT00432926: Completed Phase 2 study, sponsored by University of California, San Diego.
NCT00432926 is a Phase 2 study that has completed, run by University of California, San Diego. The registered enrollment target is 429 participants, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (223% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00432926, a Phase 2 study, has completed, sponsored by University of California, San Diego.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 429 participants
- Enrollment target
Study Summary
This study tests the effectiveness of a behavioral intervention to reduce sexual risk behavior in HIV-positive, methamphetamine-using men who have sex with men (MSM). It builds on the findings of a previous study (R01 DA012116, "Promoting safer sex in HIV+ homosexual and bisexual men who use methamphetamine"). That study achieved significant short-term results that eroded over time. Accordingly, this study hypothesizes that the addition of a maintenance component to the already proven counseling and educational components of the treatment model will result in longer-lasting positive effects.
Interventions
- BEHAVIORAL Attention control
- BEHAVIORAL EDGE counseling, no maintenance
- BEHAVIORAL EDGE counseling, plus maintenance
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 429 participants |
| Start Date | 2007-02 |
| Est. Completion | 2012-04 |
| Phase | Phase 2 |
What the finished NCT00432926 record still lists
NCT00432926 is an interventional study that assigns participants to a tested intervention. The registered 429 participants enrollment target is mid-sized for trials with a published cap, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (223% higher).
The record links to 0 conditions, and to 3 interventions - of which Attention control is the first listed.
NCT00432926 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00432926 about?
NCT00432926 is a clinical study titled "Behavior Change and Maintenance Intervention for HIV+ MSM Methamphetamine Users". This study tests the effectiveness of a behavioral intervention to reduce sexual risk behavior in HIV-positive, methamphetamine-using men who have sex with men (MSM). It builds on the findings of a previous study (R01 DA012116, "Promoting safer sex in HIV+ homosexual and bisexual men who use methamp...
What is the current status of trial NCT00432926?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 429 participants. The study started on 2007-02. Estimated completion is 2012-04.
What interventions are being tested in trial NCT00432926?
The interventions under investigation include: Attention control (BEHAVIORAL), EDGE counseling, no maintenance (BEHAVIORAL), EDGE counseling, plus maintenance (BEHAVIORAL).
Who is sponsoring clinical trial NCT00432926?
This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00432926's enrollment target sits among peer trials
429 91st of 2000 higher than 1,910 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05932862 · 429 participants · Phase 1
A Phase 1 Study of XL309 (ISM3091) Alone and in Combination in Participants With Advanced Solid Tumors
- NCT05327023 · 430 participants · Phase 1
Donor Lymphocyte Infusion After Allogeneic Hematopoietic Cell Transplantation for High-Risk Hematologic Malignancies
- NCT05457985 · 430 participants · NA
Testing Adaptive Interventions to Improve Posttraumatic Stress Disorder Treatment Outcomes in Federally Qualified Health Centers
- NCT05532982 · 430 participants
Parkinson's Disease in Asian Americans
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia